Literature DB >> 7490827

Neodymium:YAG laser coagulation prostatectomy: 3 years of experience with 227 patients.

J N Kabalin1, G Bite, S Doll.   

Abstract

PURPOSE: For 3 years we prospectively followed a cumulative cohort of men who underwent neodymium:YAG laser coagulation prostatectomy to relieve bladder outlet obstruction to determine the safety, efficacy and durability of this procedure.
MATERIALS AND METHODS: A total of 227 men with symptomatic bladder outlet obstruction was treated with the Urolase side-firing laser fiber between October 15, 1991 and October 15, 1994. Voiding outcomes, including peak urinary flow rates, residual urine volumes and American Urological Association symptom scores, were measured with time, and immediate and long-term complications were assessed.
RESULTS: Median patient followup was 26 months (maximum 42). Significant improvement occurred in all measured voiding parameters, including 133% in peak flow rates and 61% in symptom scores 1 year postoperatively. Overall 87% of patients noticed improved quality of life as a result of surgery. Minimum postoperative followup was 6 months in all cases. Complications included prostatitis in 2.6% of patients, urethral stricture in 1.8%, bladder neck contracture in 4.4% and reoperation for residual prostate tissue in 5.3%.
CONCLUSIONS: Neodymium:YAG laser coagulation of the prostate represents an efficacious surgical intervention for symptomatic bladder outlet obstruction with minimal associated morbidity. Voiding outcomes are durable through 3 years.

Entities:  

Mesh:

Year:  1996        PMID: 7490827     DOI: 10.1016/s0022-5347(01)66588-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Economic impact of surgical intervention in the treatment of benign prostatic hyperplasia.

Authors:  John M Hollingsworth; John T Wei
Journal:  Rev Urol       Date:  2006

2.  Laser prostatectomy: checkup on the promises.

Authors:  J Choi; E F Ikeguchi; A E Te; S A Kaplan
Journal:  Rev Urol       Date:  1999

Review 3.  The impact of minimally invasive surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function: a systematic review.

Authors:  Ryan W Frieben; Hao-Cheng Lin; Peter P Hinh; Francesco Berardinelli; Steven E Canfield; Run Wang
Journal:  Asian J Androl       Date:  2010-05-17       Impact factor: 3.285

Review 4.  Changing therapeutic regimens in benign prostatic hyperplasia. Clinical and economic considerations.

Authors:  H J Stoevelaar; J McDonnell
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

5.  [The 80 W potassium-titanium-phosphate (KTP) laser vaporization of the prostate. Technique and 6 month follow-up after 70 procedures].

Authors:  A Bachmann; O Reich; St Wyler; R Ruszat; R Casella; T Gasser; A Hofstetter; T Sulser
Journal:  Urologe A       Date:  2004-10       Impact factor: 0.639

6.  Differences in stress response between patients undergoing transurethral resection versus endoscopic laser ablation of the prostate for benign prostatic hyperplasia.

Authors:  Goran Bedalov; Zeljko Bartolin; Damir Puskar; Ivan Savić; Ivana Bedalov; Marija Rudolf; Drago Batinić
Journal:  Lasers Med Sci       Date:  2007-04-28       Impact factor: 3.161

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.